CEACAM5

Clinical trials for CEACAM5 explained in plain language.

Never miss a new study

Get alerted when new CEACAM5 trials appear

Sign up with your email to follow new studies for CEACAM5, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Smart drug targets two cancer weaknesses at once

Disease control Not yet recruiting

This trial tests a new drug called AN4035 in people with advanced solid tumors that have RAS mutations and high levels of the CEACAM5 protein. The drug is designed to seek out cancer cells carrying CEACAM5 and deliver a payload that blocks RAS, a key driver of cancer growth. The …

Matched conditions: CEACAM5

Phase: PHASE1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control

Last updated Jul 16, 2026 00:00 UTC

CEACAM5

Get alerted when new CEACAM5 trials appear

Smart drug targets two cancer weaknesses at once